Variations in the management and outcome of non-small cell lung cancer in Ontario
- 1 August 1994
- journal article
- clinical trial
- Published by Elsevier BV in Radiotherapy and Oncology
- Vol. 32 (2), 106-115
- https://doi.org/10.1016/0167-8140(94)90096-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?Journal of Clinical Oncology, 1993
- Radiation therapy: A long term cost benefit analysis in a North American RegionClinical Oncology, 1992
- Signiicant Effect of Adjuvant Chemotherapy on Survival in Locally Advanced Non-Small-Cell Lung CarcinomaJNCI Journal of the National Cancer Institute, 1992
- Treatment strategies for advanced and metastatic cancer in EuropeRadiotherapy and Oncology, 1991
- Inoperable non-small-cell lung cancer (NSCLC): a Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractionsBritish Journal of Cancer, 1991
- Economic Evaluation of Trends in Cancer Therapy: Marginal or Average Costs?International Journal of Technology Assessment in Health Care, 1991
- A Randomized Trial of Induction Chemotherapy plus High-Dose Radiation versus Radiation Alone in Stage III Non-Small-Cell Lung CancerNew England Journal of Medicine, 1990
- Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer.Journal of Clinical Oncology, 1990
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- The patterns of care study in clinical radiation therapy—a retrospective assessment of quality of careStatistics in Medicine, 1984